There is a newer version
of
this Section
2017 Maryland Code
Health - General
Title 13 - Miscellaneous Health Care Programs
Subtitle 35 - Co-Prescribing of Opioid Overdose Reversal Drugs
§ 13-3502. Establishment of guidelines for co-providing opioid overdose reversal drugs.
Universal Citation: MD Health-Gen Code § 13-3502 (2017)
- (a) In general. -- The Secretary shall establish guidelines for the co-prescribing of opioid overdose reversal drugs that are applicable to all licensed health care providers in the State who are authorized by law to prescribe a monitored prescription drug, as defined in ยง 21-2A-01 of this article.
- (b) Contents. -- The guidelines established under subsection (a) of this section shall address the co-prescribing of opioid overdose reversal drugs for patients who are:
- (1) At an elevated risk of overdose; and
- (2)
- (i) Receiving opioid therapy for chronic pain;
- (ii) Receiving a prescription for benzodiazepines; or
- (iii) Being treated for opioid use disorders.
Disclaimer: These codes may not be the most recent version. Maryland may have more current or accurate information. We make no warranties or guarantees about the accuracy, completeness, or adequacy of the information contained on this site or the information linked to on the state site. Please check official sources.
This site is protected by reCAPTCHA and the Google
Privacy Policy and
Terms of Service apply.
